vs
DXP ENTERPRISES INC（DXPE）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是DXP ENTERPRISES INC的1.5倍（$772.1M vs $527.4M），Revvity净利率更高（12.7% vs 4.3%，领先8.4%），DXP ENTERPRISES INC同比增速更快（12.0% vs 5.9%），Revvity自由现金流更多（$161.8M vs $34.5M），过去两年DXP ENTERPRISES INC的营收复合增速更高（13.1% vs 9.0%）
DXP Enterprises Inc.是一家领先的工业分销企业，提供维护、维修、运营（MRO）用品、流体处理设备、泵系统及相关技术服务，主要服务制造业、能源、矿业、建筑等领域客户，核心市场覆盖北美地区。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
DXPE vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.5倍
$527.4M
营收增速更快
DXPE
高出6.1%
5.9%
净利率更高
RVTY
高出8.4%
4.3%
自由现金流更多
RVTY
多$127.3M
$34.5M
两年增速更快
DXPE
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $527.4M | $772.1M |
| 净利润 | $22.8M | $98.4M |
| 毛利率 | 31.6% | — |
| 营业利润率 | 8.8% | 14.5% |
| 净利率 | 4.3% | 12.7% |
| 营收同比 | 12.0% | 5.9% |
| 净利润同比 | 6.9% | 3.9% |
| 每股收益（稀释后） | $1.38 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXPERVTY
| Q4 25 | $527.4M | $772.1M | ||
| Q3 25 | $513.7M | $698.9M | ||
| Q2 25 | $498.7M | $720.3M | ||
| Q1 25 | $476.6M | $664.8M | ||
| Q4 24 | $470.9M | $729.4M | ||
| Q3 24 | $472.9M | $684.0M | ||
| Q2 24 | $445.6M | $691.7M | ||
| Q1 24 | $412.6M | $649.9M |
净利润DXPERVTY
| Q4 25 | $22.8M | $98.4M | ||
| Q3 25 | $21.6M | $46.7M | ||
| Q2 25 | $23.6M | $53.9M | ||
| Q1 25 | $20.6M | $42.2M | ||
| Q4 24 | $21.4M | $94.6M | ||
| Q3 24 | $21.1M | $94.4M | ||
| Q2 24 | $16.7M | $55.4M | ||
| Q1 24 | $11.3M | $26.0M |
毛利率DXPERVTY
| Q4 25 | 31.6% | — | ||
| Q3 25 | 31.4% | 53.6% | ||
| Q2 25 | 31.6% | 54.5% | ||
| Q1 25 | 31.5% | 56.5% | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.9% | 56.3% | ||
| Q2 24 | 30.9% | 55.7% | ||
| Q1 24 | 30.0% | 54.6% |
营业利润率DXPERVTY
| Q4 25 | 8.8% | 14.5% | ||
| Q3 25 | 8.5% | 11.7% | ||
| Q2 25 | 9.2% | 12.6% | ||
| Q1 25 | 8.5% | 10.9% | ||
| Q4 24 | 8.3% | 16.3% | ||
| Q3 24 | 8.4% | 14.3% | ||
| Q2 24 | 8.4% | 12.4% | ||
| Q1 24 | 7.1% | 6.8% |
净利率DXPERVTY
| Q4 25 | 4.3% | 12.7% | ||
| Q3 25 | 4.2% | 6.7% | ||
| Q2 25 | 4.7% | 7.5% | ||
| Q1 25 | 4.3% | 6.4% | ||
| Q4 24 | 4.5% | 13.0% | ||
| Q3 24 | 4.5% | 13.8% | ||
| Q2 24 | 3.7% | 8.0% | ||
| Q1 24 | 2.7% | 4.0% |
每股收益（稀释后）DXPERVTY
| Q4 25 | $1.38 | $0.86 | ||
| Q3 25 | $1.31 | $0.40 | ||
| Q2 25 | $1.43 | $0.46 | ||
| Q1 25 | $1.25 | $0.35 | ||
| Q4 24 | $1.28 | $0.77 | ||
| Q3 24 | $1.27 | $0.77 | ||
| Q2 24 | $1.00 | $0.45 | ||
| Q1 24 | $0.67 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $303.8M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $498.4M | $7.3B |
| 总资产 | $1.7B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXPERVTY
| Q4 25 | $303.8M | $919.9M | ||
| Q3 25 | $123.8M | $931.4M | ||
| Q2 25 | $112.9M | $991.8M | ||
| Q1 25 | $114.3M | $1.1B | ||
| Q4 24 | $148.3M | $1.2B | ||
| Q3 24 | $35.0M | $1.2B | ||
| Q2 24 | $49.9M | $2.0B | ||
| Q1 24 | $139.7M | $1.7B |
股东权益DXPERVTY
| Q4 25 | $498.4M | $7.3B | ||
| Q3 25 | $488.3M | $7.4B | ||
| Q2 25 | $468.1M | $7.6B | ||
| Q1 25 | $444.7M | $7.6B | ||
| Q4 24 | $422.8M | $7.7B | ||
| Q3 24 | $402.4M | $7.9B | ||
| Q2 24 | $384.7M | $7.9B | ||
| Q1 24 | $375.5M | $7.8B |
总资产DXPERVTY
| Q4 25 | $1.7B | $12.2B | ||
| Q3 25 | $1.4B | $12.1B | ||
| Q2 25 | $1.4B | $12.4B | ||
| Q1 25 | $1.4B | $12.4B | ||
| Q4 24 | $1.3B | $12.4B | ||
| Q3 24 | $1.2B | $12.8B | ||
| Q2 24 | $1.2B | $13.4B | ||
| Q1 24 | $1.2B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $37.8M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $34.5M | $161.8M |
| 自由现金流率自由现金流/营收 | 6.5% | 21.0% |
| 资本支出强度资本支出/营收 | 0.6% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.65× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $54.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流DXPERVTY
| Q4 25 | $37.8M | $182.0M | ||
| Q3 25 | $34.9M | $138.5M | ||
| Q2 25 | $18.6M | $134.3M | ||
| Q1 25 | $3.0M | $128.2M | ||
| Q4 24 | $32.1M | $174.2M | ||
| Q3 24 | $28.3M | $147.9M | ||
| Q2 24 | $14.7M | $158.6M | ||
| Q1 24 | $27.0M | $147.6M |
自由现金流DXPERVTY
| Q4 25 | $34.5M | $161.8M | ||
| Q3 25 | $28.1M | $120.0M | ||
| Q2 25 | $8.3M | $115.5M | ||
| Q1 25 | $-16.9M | $112.2M | ||
| Q4 24 | $22.7M | $149.8M | ||
| Q3 24 | $24.4M | $125.6M | ||
| Q2 24 | $5.9M | $136.6M | ||
| Q1 24 | $24.1M | $129.7M |
自由现金流率DXPERVTY
| Q4 25 | 6.5% | 21.0% | ||
| Q3 25 | 5.5% | 17.2% | ||
| Q2 25 | 1.7% | 16.0% | ||
| Q1 25 | -3.6% | 16.9% | ||
| Q4 24 | 4.8% | 20.5% | ||
| Q3 24 | 5.2% | 18.4% | ||
| Q2 24 | 1.3% | 19.7% | ||
| Q1 24 | 5.8% | 20.0% |
资本支出强度DXPERVTY
| Q4 25 | 0.6% | 2.6% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 2.1% | 2.6% | ||
| Q1 25 | 4.2% | 2.4% | ||
| Q4 24 | 2.0% | 3.4% | ||
| Q3 24 | 0.8% | 3.3% | ||
| Q2 24 | 2.0% | 3.2% | ||
| Q1 24 | 0.7% | 2.7% |
现金转化率DXPERVTY
| Q4 25 | 1.65× | 1.85× | ||
| Q3 25 | 1.61× | 2.97× | ||
| Q2 25 | 0.79× | 2.49× | ||
| Q1 25 | 0.14× | 3.03× | ||
| Q4 24 | 1.50× | 1.84× | ||
| Q3 24 | 1.34× | 1.57× | ||
| Q2 24 | 0.88× | 2.87× | ||
| Q1 24 | 2.38× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXPE
| Service Centers | $356.2M | 68% |
| Innovative Pumping Solutions | $110.0M | 21% |
| Supply Chain Services | $61.2M | 12% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
